Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
1.
AIDS ; 11(14): 1773-8, 1997 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-9386813

RESUMEN

OBJECTIVE: To determine the effect of sun exposure on HIV progression. DESIGN: Cross-sectional survey nested within a longitudinal cohort study. SETTING: The Multicenter AIDS Cohort Study. PARTICIPANTS: A total of 1155 white HIV-seronegative and 496 white HIV-seropositive homosexual men, of whom 142 seroconverted during the study. MAIN OUTCOME MEASURES: T-helper lymphocyte decline and AIDS. RESULTS: No positive correlation was found between the development of AIDS or loss of T-helper lymphocytes and (i) phenotypic characteristics associated with enhanced ultraviolet radiation (UVR) sensitivity (hair or eye color, skin type), or (ii) reported UVR exposure (sun lamp/tanning bed use, frequency of beach vacations, sunscreen use), or (iii) composite score of UVR sensitivity and exposure history. The composite scores and individual measures of risk were not correlated with rate of T-helper lymphocyte decline (slope) based upon rank correlation (correlation coefficient, 0.04; P = 0.32). In fact, individuals purposefully seeking the sun had slower T-helper lymphocyte declines. Sensitivity to UVR was also not significantly associated with AIDS [odds ratio (OR), 1.11 per unit of higher composite score; 95% confidence interval (CI), 0.66-1.88; P = 0.63]. Among individuals who were HIV-infected at baseline, those who have been purposely seeking sun exposure were less likely to have AIDS (OR, 0.67; 95% CI, 0.39-1.11; P = 0.12). CONCLUSIONS: These data suggest that phenotypic characteristics of high UVR sensitivity and exposure are not highly correlated with decline in T-helper lymphocyte count or with progression to AIDS.


Asunto(s)
Seropositividad para VIH/fisiopatología , Homosexualidad Masculina , Rayos Ultravioleta , Adulto , Recuento de Células , Estudios de Cohortes , Estudios Transversales , Progresión de la Enfermedad , Seropositividad para VIH/inmunología , Humanos , Estudios Longitudinales , Masculino , Luz Solar , Linfocitos T Colaboradores-Inductores/inmunología
2.
Medicine (Baltimore) ; 73(3): 153-60, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-8190038

RESUMEN

A consensus regarding adequate screening to detect early malignancy in the setting of dermatomyositis (DMM) has yet to be reached. This issue is particularly relevant with regard to ovarian cancer, as early detection with routine examinations, ultrasound, and abdominal CT may not be successful. Four of 15 women diagnosed with and seen in our department for DMM between 1986 and 1993 were subsequently diagnosed with metastatic papillary serous ovarian carcinoma. One additional patient developed metastatic pelvic papillary adenocarcinoma, believed to be of ovarian origin. These diagnoses of advanced cancer were unexpected, as all women had undergone repeated cancer screenings beyond what is normally recommended for patients with DMM. The 5 women were strikingly similar in their initial presentations and subsequent courses. In each, the diagnosis of DMM was delayed from 2 to 10 months, as they were initially misdiagnosed with a photoinduced or contact dermatitis. All except 1 had severe, recalcitrant skin disease despite attempted therapy with antimalarial and immunosuppressive agents. All 4 patients who survived the postoperative period after tumor debulking showed either improvement or resolution of their DMM. It appears that women with DMM have an increased incidence of ovarian cancer, which is usually diagnosed months to a few years (range, 0 d to 6 y) after DMM has been diagnosed. Although recommendations have been made regarding cancer screening in these individuals, recommendations for initial and surveillance examinations vary from routine history and physical examination to evaluations including extensive radiologic evaluation.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Cistadenocarcinoma Papilar/diagnóstico , Dermatomiositis/diagnóstico , Neoplasias Ováricas/diagnóstico , Edad de Inicio , Anciano , Antígenos de Carbohidratos Asociados a Tumores/análisis , Biopsia , Cistadenocarcinoma Papilar/complicaciones , Cistadenocarcinoma Papilar/cirugía , Dermatomiositis/complicaciones , Dermatomiositis/inmunología , Femenino , Humanos , Laparotomía , Persona de Mediana Edad , Neoplasias Ováricas/complicaciones , Neoplasias Ováricas/cirugía , Pruebas Cutáneas
3.
Arch Dermatol ; 128(5): 653-6, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1533501

RESUMEN

BACKGROUND: The correct selection of vehicles for patch testing specific substances is essential in the evaluation of suspected allergic contact dermatitis. A reaction to a chemical may be dependent not only on the concentration tested but also on the vehicle in which it is tested. In cases of suspected allergic contact dermatitis to minoxidil, propylene glycol, and alcohol formulations, patch testing is usually done with the formulation of minoxidil in alcohol and/or minoxidil in petrolatum. OBSERVATIONS: An acute contact dermatitis of the scalp developed in a 34-year-old white man while he was using minoxidil (Rogaine [2% minoxidil in a solution of alcohol 60% vol/vol, propylene glycol, and water]) solution. Patch testing with 2% minoxidil in alcohol and 2% minoxidil in petrolatum showed no reaction, while both Rogaine solution and 2% minoxidil in propylene glycol produced papulovesicular plaques. CONCLUSIONS: Patch testing in cases of suspected minoxidil allergic contact dermatitis should include testing with minoxidil in propylene glycol. Omitting this testing may cause diagnoses and therapeutic formulation alternatives to go unrecognized.


Asunto(s)
Erupciones por Medicamentos/diagnóstico , Minoxidil/efectos adversos , Pruebas del Parche/métodos , Vehículos Farmacéuticos , Adulto , Erupciones por Medicamentos/etiología , Humanos , Masculino
4.
Arch Dermatol ; 131(10): 1128-33, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7574828

RESUMEN

BACKGROUND AND DESIGN: To date, studies of the effectiveness of sunscreens in preventing UVB-induced suppression of contact hypersensitivity in humans have not been published. Several studies in mice of the protection afforded by sunscreens from UVB-induced suppression of contact hypersensitivity and rejection of transplanted skin cancers have yielded dissimilar results, ranging from "no" to "complete" protection. We sought to determine whether the effect of preapplication of a sun protection factor (SPF) 29 sunscreen (containing octyl methoxycinnamate, oxybenzone, and octyl salicylate) could prevent local UVB-induced suppression of contact hypersensitivity to dinitrochlorobenzene (DNCB). Nineteen subjects received either three minimal erythema doses of UVB daily on three consecutive days (UVB group) or sunscreen followed by this same dose of UVB irradiation (sunscreen plus UVB group) to a 16-cm2 area of the buttock. One day after completion of irradiation, DNCB was applied to this buttock site, and 2 weeks later, forearm challenge with four different concentrations of DNCB was performed. A control group of 10 subjects underwent DNCB testing as above, but with no prior exposure to UVB (no-UVB group). RESULTS: The UVB group had a reduced response rate to all challenge doses of DNCB (3.125, 6.25, and 8.8 micrograms), except for the highest dose (12.5 micrograms) compared with the no-UVB control group (Fisher's Exact test, P < or = .008), and compared with the sunscreen plus UVB group (P < or = .02). The no-UVB and sunscreen plus UVB groups showed no significant differences in response rates to any of the doses of DNCB tested (P > or = .53). CONCLUSIONS: These results indicate that application of a sunscreen with over ninefold greater protection than that needed to prevent erythema prior to localized UVB radiation prevents localized UVB-induced suppression of contact hypersensitivity. Further studies are needed to determine whether sunscreens providing less protection, yet still preventing erythema, adequately prevent suppression of contact hypersensitivity, a possible surrogate marker for skin cancer tumor antigen recognition and rejection.


Asunto(s)
Tolerancia Inmunológica/efectos de los fármacos , Tolerancia Inmunológica/efectos de la radiación , Protectores Solares/farmacología , Rayos Ultravioleta , Adulto , Dermatitis por Contacto/inmunología , Dinitroclorobenceno/antagonistas & inhibidores , Humanos , Irritantes/farmacología , Persona de Mediana Edad
5.
Arch Dermatol ; 130(4): 476-80, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8166485

RESUMEN

BACKGROUND: Only five cases of purely macular hypopigmented mycosis fungoides have been published in the literature. These patients all had clinical evidence of disease 7 months to 10 years prior to histologic diagnosis, suggesting that this clinical presentation of mycosis fungoides is easily misdiagnosed. OBSERVATIONS: Three African-American males, ages 9, 15, and 22 years, were found to have mycosis fungoides on evaluation of skin biopsy specimens after initially being clinically diagnosed with, and treated for, pityriasis alba. All three had typical histopathologic changes and cell marker studies showing a relative loss of the CD7 antigen, which is normally present on the majority of T cells. One patient who was treated with methoxsalen plus UV light (PUVA) therapy had clearance of his disease clinically and histologically. CONCLUSION: From the literature, it would appear that macular hypopigmented mycosis fungoides is exceptionally rare. This perceived rarity may be inaccurate due to either relative underreporting, incorrect diagnoses, or both. From the eight patients now reported to date, it may be said that hypopigmented mycosis fungoides may be seen in nonwhite individuals and more often than not, has onset before age 20 years.


Asunto(s)
Hipopigmentación/patología , Micosis Fungoide/patología , Neoplasias Cutáneas/patología , Adolescente , Adulto , Negro o Afroamericano , Niño , Errores Diagnósticos , Humanos , Hipopigmentación/etiología , Masculino , Micosis Fungoide/complicaciones , Neoplasias Cutáneas/complicaciones
6.
Arch Dermatol ; 134(5): 595-8, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9606329

RESUMEN

The possibility that there is an increased risk of melanoma in patients with psoriasis treated with psoralen-UV-A (PUVA) therapy has raised concern on the part of physicians and patients about the long-term safety of this treatment. In response to this concern, the National Psoriasis Foundation sponsored a workshop at which invited participants with expertise in PUVA therapy, psoriasis treatment, melanoma and nonmelanoma skin cancer, and epidemiological and clinical trials were asked to develop a consensus on the following 3 issues: the risk of long-term adverse effects of PUVA therapy with emphasis on nonmelanoma and melanoma skin cancer; the guidelines for physicians and patients for selection and use of PUVA therapy with consideration of the risk-benefit ratio of this treatment compared with the risk-benefit ratios of alternative treatments; and the directions for further evaluation of the long-term effects Of PUVA therapy.


Asunto(s)
Melanoma/inducido químicamente , Terapia PUVA/efectos adversos , Neoplasias Cutáneas/inducido químicamente , Humanos , Psoriasis/tratamiento farmacológico , Riesgo , Factores de Tiempo
7.
Photochem Photobiol ; 71(6): 700-5, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10857365

RESUMEN

Cutaneous and systemic immune function are believed to play an important role in cutaneous carcinogenesis. We therefore sought to determine whether the suntan parlor radiation sources commonly used in the United States cause measurable qualitative suppression of immune function and quantitative alterations in circulating T cell subpopulations. Subjects (n = 22) were recruited and randomly assigned to receive suntan parlor exposures (10 full-body UV exposures over a 2 week period, shielding only the right flexural arm) or no exposure. Baseline circulating T lymphocyte subpopulations (T helper lymphocyte, CD4; T suppressor/cytotoxic lymphocyte, CD8) were measured. Two weeks later (upon completion of UV exposures for those in this group), circulating T cell subpopulations were measured and dinitrochlorobenzene (DNCB) sensitization (in the UV group, on the UV-exposed buttock) was performed. Subsequent DNCB elicitation was performed in a bilateral fashion (in the UV group, on the right UV-shielded and the left UV-exposed upper arm). We found that subjects in the UV group demonstrated localized suppression of contact hypersensitivity sensitization and elicitation and also an increase in circulating CD8 cells when compared to the control group (P < or = 0.05). We conclude that suntan parlor exposures, as typically received in this country, suppress contact hypersensitivity and increase the circulating T suppressor/cytotoxic cell number quantity.


Asunto(s)
Dermatitis por Contacto/inmunología , Helioterapia , Hipersensibilidad Tardía/inmunología , Adulto , Femenino , Humanos , Células Asesinas Naturales/citología , Masculino , Subgrupos de Linfocitos T
8.
Dermatol Clin ; 12(3): 491-9, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7923946

RESUMEN

Although it appears that the incidence of allergic contact dermatitis is lower in patients with atopic dermatitis than in patients with other forms of dermatitis, studies have shown that a significant number of atopics demonstrate allergic contact dermatitis on testing. This article presents a review of the larger studies that have been performed in atopic individuals as well as recommendations for patch testing.


Asunto(s)
Dermatitis Atópica/diagnóstico , Pruebas del Parche , Adulto , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Profesional/diagnóstico , Humanos , Factores de Riesgo
9.
Cutis ; 48(3): 213-6, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1935251

RESUMEN

We report a patient with a type IB nevus of Ota whose lesion did not appear until she was thirty years old. To our knowledge, this represents the oldest age of a patient at clinical onset of nevus of Ota. The diagnosis, implications, and treatment of nevus of Ota are reviewed.


Asunto(s)
Nevo de Ota , Neoplasias Cutáneas , Adulto , Factores de Edad , Neoplasias Faciales/patología , Femenino , Humanos , Nevo de Ota/patología , Piel/patología , Neoplasias Cutáneas/patología
10.
Cutis ; 61(4): 229-32, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9564598

RESUMEN

Two patients with Cronkhite-Canada syndrome (CCS) are reported, both of whom had diffuse alopecia, nail and skin changes, gastrointestinal polyposis, diarrhea, and wasting. A scalp biopsy was performed in one patient, and the specimen showed a marked noninflammatory loss of follicular units, miniaturization of the hair shafts, markedly dilated follicles, and a heavy deposition of glycosaminoglycans in the reticular dermis. This patient responded to prednisone therapy. The other patient was found to have elevated gastric acid levels and responded to ranitidine therapy. The conditions of both patients are now in remission two and six years later, respectively. Our patients have shown a temporally related remission of disease during treatment with prednisone and ranitidine, suggesting that each agent may be effective in CCS. However, randomized placebo-controlled trials are needed to prove the efficacy of these therapies. Further investigation of the histopathologic features of the associated alopecia may determine its cause.


Asunto(s)
Alopecia/complicaciones , Pólipos Intestinales/complicaciones , Cuero Cabelludo/patología , Anciano , Alopecia/tratamiento farmacológico , Alopecia/patología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Pólipos Intestinales/tratamiento farmacológico , Enfermedades de la Uña/complicaciones , Prednisona/uso terapéutico , Ranitidina/uso terapéutico , Síndrome
11.
Mol Oral Microbiol ; 26(3): 210-20, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21545698

RESUMEN

Primary gingival epithelial cells were cultured in multilayers as a model for the study of interactions with oral bacteria associated with health and periodontal disease. Multilayers maintained at an air-liquid interface in low-calcium medium displayed differentiation and cytokeratin properties characteristic of junctional epithelium. Multilayers were infected with fluorescently labeled Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum or Streptococcus gordonii, and bacterial association was determined by confocal microscopy and quantitative image analysis. Porphyromonas gingivalis invaded intracellularly and spread from cell to cell; A. actinomycetemcomitans and F. nucleatum remained extracellular and showed intercellular movement through the multilayer; whereas S. gordonii remained extracellular and predominantly associated with the superficial cell layer. None of the bacterial species disrupted barrier function as measured by transepithelial electrical resistance. P. gingivalis did not elicit secretion of proinflammatory cytokines. However, A. actinomycetemcomitans and S. gordonii induced interleukin-1ß (IL-1ß), tumor necrosis factor-α (TNF-α), IL-6 and IL-8 secretion; and F. nucleatum stimulated production of IL-1ß and TNF-α. Aggregatibacter actinomycetemcomitans, F. nucleatum and S. gordonii, but not P. gingivalis, increased levels of apoptosis after 24 h infection. The results indicate that the organisms with pathogenic potential were able to traverse the epithelium, whereas the commensal bacteria did not. In addition, distinct host responses characterized the interaction between the junctional epithelium and oral bacteria.


Asunto(s)
Bacterias/patogenicidad , Inserción Epitelial/microbiología , Encía/microbiología , Mucosa Bucal/microbiología , Aggregatibacter actinomycetemcomitans/inmunología , Aggregatibacter actinomycetemcomitans/fisiología , Apoptosis/fisiología , Bacterias/inmunología , Técnicas de Cultivo de Célula , Inserción Epitelial/citología , Inserción Epitelial/inmunología , Células Epiteliales/inmunología , Células Epiteliales/microbiología , Fusobacterium nucleatum/inmunología , Fusobacterium nucleatum/fisiología , Encía/citología , Encía/inmunología , Interacciones Huésped-Patógeno , Humanos , Procesamiento de Imagen Asistido por Computador , Mediadores de Inflamación/análisis , Interleucina-1beta/análisis , Interleucina-6/análisis , Interleucina-8/análisis , Queratina-13/análisis , Queratina-9/análisis , Microscopía Confocal , Enfermedades Periodontales/microbiología , Porphyromonas gingivalis/inmunología , Porphyromonas gingivalis/fisiología , Streptococcus gordonii/inmunología , Streptococcus gordonii/fisiología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/análisis
12.
Mol Oral Microbiol ; 26(6): 365-73, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22053964

RESUMEN

An association between the gram-positive anaerobe Filifactor alocis and periodontal disease has recently emerged; however, possible pathogenic mechanisms have not been investigated. In this study we examined the responses of primary cultures of gingival epithelial cells (GECs) to infection with F. alocis. Secretion of the pro-inflammatory cytokines interleukin-1ß, interleukin-6 and tumor necrosis factor-α from GECs was stimulated by F. alocis infection. F. alocis also induced apoptosis in GECs through pathways that involved caspase-3 but not caspase-9. Apoptosis was coincident with inhibition of mitogen-activated protein kinase kinase (MEK) activation. These results show that F. alocis has characteristics in common with established periodontal pathogens and has the potential to contribute to periodontal tissue destruction.


Asunto(s)
Fusobacterium/patogenicidad , Encía/microbiología , Apoptosis/inmunología , Western Blotting , Caspasa 3/análisis , Caspasa 9/análisis , Células Cultivadas , Técnicas de Cocultivo , Células Epiteliales/inmunología , Células Epiteliales/microbiología , Citometría de Flujo , Fusobacterium/inmunología , Infecciones por Fusobacterium/inmunología , Encía/inmunología , Humanos , Mediadores de Inflamación/análisis , Interleucina-1beta/análisis , Interleucina-6/análisis , Sistema de Señalización de MAP Quinasas/inmunología , Microscopía Confocal , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/análisis
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda